João Santinha

Mr. João Santinha

Champalimaud Foundation, Lisbon, Lisboa, Portugal
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2024 in Diagnostic and Interventional Radiology
Verified
Journal Article
Open access
BKBurak Kocak
Burak Kocak
APAndrea Ponsiglione
Andrea Ponsiglione
Arnaldo StanzioneArnaldo Stanzione
Arnaldo Stanzione
CBChristian Blüthgen
Christian Blüthgen
JSJoão Santinha
João Santinha
Renato CuocoloRenato Cuocolo
Renato Cuocolo
Bias in artificial intelligence for medical imaging: fundamentals, detection, avoidance, mitigation, challenges, ethics, and prospects - Diagnostic and Interventional Radiology

25 October 2024 in European Radiology
Verified
Journal Article
Open access
PDF file
JSJoão Santinha
João Santinha
Daniel Pinto dos SantosDaniel Pinto dos Santos
Daniel Pinto dos Santos
FLFabian Laqua
Fabian Laqua
JVJacob Visser
Jacob Visser
KLKevin B. W. Groot Lipman
Kevin B. W. Groot Lipman
TDTugba Akinci D'Antonoli
Tugba Akinci D'Antonoli
Radiomics is a method to extract detailed information from diagnostic images that cannot be perceived by the naked eye. Although radiomics research carries great potential to improve clinical decision-making, its inherent methodological complexities make it difficult to comprehend every step of the analysis, often causing reproducibility and generalizability issues that hinder clinical adoption. Critical steps in the radiomics analysis and model development pipeline—such as image, application of image filters, and selection of feature extraction parameters—can greatly affect the values of radiomic features. Moreover, common errors in data partitioning, model comparison, fine-tuning, assessment, and calibration can reduce reproducibility and impede clinical translation. Clinical adoption of radiomics also requires a deep understanding of model explainability and the development of intuitive interpretations of radiomic features. To address these challenges, it is essential for radiomics model developers and clinicians to be well-versed in current best practices. Proper knowledge and application of these practices is crucial for accurate radiomics feature extraction, robust model development, and thorough assessment, ultimately increasing reproducibility, generalizability, and the likelihood of successful clinical translation. In this article, we have provided researchers with our recommendations along with practical examples to facilitate good research practices in radiomics. Key Points: Radiomics’ inherent methodological complexity should be understood to ensure rigorous radiomic model development to improve clinical decision-making. Adherence to radiomics-specific checklists and quality assessment tools ensures methodological rigor. Use of standardized radiomics tools and best practices enhances clinical translation of radiomics models.

23 October 2020 in Cancers
Verified
Journal Article
Open access
PDF file
DTDavid Tobaly
David Tobaly
JSJoão Santinha
João Santinha
RSRiccardo Sartoris
Riccardo Sartoris
MBMarco Dioguardi Burgio
Marco Dioguardi Burgio
CMCelso Matos
Celso Matos
Valérie VilgrainValérie Vilgrain
Valérie Vilgrain
To assess the performance of CT-based radiomics analysis in differentiating benign from malignant intraductal papillary mucinous neoplasms of the pancreas (IPMN), preoperative scans of 408 resected patients with IPMN were retrospectively analyzed. IPMNs were classified as benign (low-grade dysplasia, n = 181), or malignant (high grade, n = 128, and invasive, n = 99). Clinicobiological data were reported. Patients were divided into a training cohort (TC) of 296 patients and an external validation cohort (EVC) of 112 patients. After semi-automatic tumor segmentation, PyRadiomics was used to extract radiomics features. A multivariate model was developed using a logistic regression approach. In the training cohort, 85/107 radiomics features were significantly different between patients with benign and malignant IPMNs. Unsupervised clustering analysis revealed four distinct clusters of patients with similar radiomics features patterns with malignancy as the most significant association. The multivariate model differentiated benign from malignant tumors in TC with an area under the ROC curve (AUC) of 0.84, sensitivity (Se) of 0.82, specificity (Spe) of 0.74, and in EVC with an AUC of 0.71, Se of 0.69, Spe of 0.57. This large study confirms the high diagnostic performance of preoperative CT-based radiomics analysis to differentiate between benign from malignant IPMNs.

3 August 2025 in European Radiology
Verified
Journal Article
Open access
PDF file
Michail KlontzasMichail Klontzas
Michail Klontzas
KLKevin B. W. Groot Lipman
Kevin B. W. Groot Lipman
TDTugba Akinci D'Antonoli
Tugba Akinci D'Antonoli
AAAnna Andreychenko
Anna Andreychenko
Renato CuocoloRenato Cuocolo
Renato Cuocolo
MHMerel Huisman
Merel Huisman
This article provides radiologists with practical recommendations for evaluating AI performance in radiology, ensuring alignment with clinical goals and patient safety. It outlines key performance metrics, including overlap metrics for segmentation, test-based metrics (e.g., sensitivity, specificity, and area under the receiver operating characteristic curve), and outcome-based metrics (e.g., precision, negative predictive value, F1-score, Matthews correlation coefficient, and area under the precision-recall curve). Key recommendations emphasize local validation using independent datasets, selecting task-specific metrics, and considering deployment context to ensure real-world performance matches claimed efficacy. Common pitfalls, such as overreliance on a single metric, misinterpretation in low-prevalence settings, and failure to account for clinical workflow, are addressed with mitigation strategies. Additional guidance is provided on threshold selection, prevalence-adjusted evaluation, and AI-generated image quality assessment. This guide equips radiologists to critically evaluate both commercially available and in-house developed AI tools, ensuring their safe and effective integration into clinical practice. Clinical relevance statement: This review provides guidance on selecting and interpreting AI performance metrics in radiology, ensuring clinically meaningful evaluation and safe deployment of AI tools. By addressing common pitfalls and promoting standardized reporting, it supports radiologists in making informed decisions, ultimately improving diagnostic accuracy and patient outcomes. Key Points: Radiologists must evaluate performance metrics as they reflect acceptable performance in specific datasets but do not guarantee clinical utility. Independent evaluation tailored to the clinical setting is essential . Performance metrics must align with the intended task of the AI application—segmentation, detection, or classification—and be selected based on domain knowledge and clinical context . Sensitivity, specificity, area under the ROC curve, and accuracy must be interpreted with prevalence-dependent metrics (e.g., precision, F1 score, and Matthew’s correlation coefficient) calculated for the target population to ensure safe and effective clinical use .

1 July 2022 in Radiology
Verified
Journal Article
Closed access
VKVassilis Koutoulidis
Vassilis Koutoulidis
Evangelos TerposEvangelos Terpos
Evangelos Terpos
Nikolaos PapanikolaouNikolaos Papanikolaou
Nikolaos Papanikolaou
SFSophia Fontara
Sophia Fontara
ISIOANNIS SEIMENIS
IOANNIS SEIMENIS
LMLia Angela Moulopoulos
Lia Angela Moulopoulos
Fat fraction histogram metrics had a higher performance than apparent diffusion coefficient histogram metrics at MRI examination for predicting very early (after one cycle of induction) therapy res... Background An imaging-based predictor of response could provide prognostic information early during treatment course in patients with multiple myeloma (MM). Purpose To investigate if very early cha...

1 December 2021 in Cancers
Verified
Journal Article
Open access
PDF file
ARAna Carolina Rodrigues
Ana Carolina Rodrigues
JSJoão Santinha
João Santinha
BGBernardo Galvão
Bernardo Galvão
CMCelso Matos
Celso Matos
FCFrancisco Couto
Francisco Couto
Nikolaos PapanikolaouNikolaos Papanikolaou
Nikolaos Papanikolaou
Prostate cancer is one of the most prevalent cancers in the male population. Its diagnosis and classification rely on unspecific measures such as PSA levels and DRE, followed by biopsy, where an aggressiveness level is assigned in the form of Gleason Score. Efforts have been made in the past to use radiomics coupled with machine learning to predict prostate cancer aggressiveness from clinical images, showing promising results. Thus, the main goal of this work was to develop supervised machine learning models exploiting radiomic features extracted from bpMRI examinations, to predict biological aggressiveness; 288 classifiers were developed, corresponding to different combinations of pipeline aspects, namely, type of input data, sampling strategy, feature selection method and machine learning algorithm. On a cohort of 281 lesions from 183 patients, it was found that (1) radiomic features extracted from the lesion volume of interest were less stable to segmentation than the equivalent extraction from the whole gland volume of interest; and (2) radiomic features extracted from the whole gland volume of interest produced higher performance and less overfitted classifiers than radiomic features extracted from the lesions volumes of interest. This result suggests that the areas surrounding the tumour lesions offer relevant information regarding the Gleason Score that is ultimately attributed to that lesion.